Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials (Q45323630)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 December 2017
  • Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
edit
Language Label Description Also known as
English
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
scientific article published on 4 December 2017
  • Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Statements

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials (English)
0 references
Leyi Lin
Sarah L George
Erica Sondergaard
Janice Tennant
Jessica L Ansel
Kristin Mills
Michael Koren
Jill Barrett
Jason Thompson
Alison E Kosel
Peter Dawson
Andrew Hale
C Sabrina Tan
Stephen R Walsh
Keith E Meyer
James Brien
Azra Blazevic
Karla Mosby
Anne Basil
Melissa Walsh
Veronica Tonwe
Daniel F Hoft
4 December 2017
391
0 references
563-571
0 references
10120
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit